Literature DB >> 2005400

Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands.

N S Trede1, R S Geha, T Chatila.   

Abstract

Ligands that bind MHC class II (Ia) molecules, including staphylococcal exotoxins (SE) and mAb induce IL-1 and TNF secretion in human monocytes and monocytic cell lines. In this study, we have analyzed the mechanisms by which SE induce IL-1 beta and TNF-alpha production. Treatment of human peripheral blood monocytes with staphylococcal exotoxin B and toxic shock syndrome toxin-1 resulted in a biphasic increase of IL-1 beta mRNA that lasted more than 12 h and in a more transient rise in TNF-alpha mRNA. A F(ab) preparation of the anti-HLA DR mAb L243 also caused a significant increase in monokine mRNA levels. Stimulation of a monocytic cell line, THP-1, with staphylococcal exotoxin B and toxic shock syndrome toxin-1 induced a rapid rise in IL-1 beta and TNF-alpha mRNA levels. This response peaked at 1 to 3 h poststimulation and remained detectable at 12 h. Nuclear run-on transcription assays demonstrated that SE cause transcriptional activation of the IL-1 beta and TNF-alpha genes. This transcriptional activation did not require de novo protein synthesis as it was not inhibited by the protein synthesis inhibitor cycloheximide. These results define an important function for Ia molecules as regulators of cytokine gene expression and add to the understanding of the changes in cellular function induced by SE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005400

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.

Authors:  M J Litton; M Dohlsten; J Hansson; A Rosendahl; L Ohlsson; T Kalland; J Andersson; U Andersson
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy.

Authors:  Xi Wang; Bai-Ren Wang; Xi-Jing Zhang; Xiao-Li Duan; Xiang Guo; Gong Ju
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

4.  Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes.

Authors:  Rakel Carpintero; Karim J Brandt; Lyssia Gruaz; Nicolas Molnarfi; Patrice H Lalive; Danielle Burger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

5.  MHC class II exacerbates demyelination in vivo independently of T cells.

Authors:  Meenaxi M Hiremath; Vivian S Chen; Kinuko Suzuki; Jenny P Y Ting; Glenn K Matsushima
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 6.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

Review 7.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

8.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

9.  Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.

Authors:  A H Hajeer; N Snowden; P Wilson; S Drover; W E Ollier
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells.

Authors:  J E Brinchmann; G Gaudernack; E Thorsby; F Vartdal
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.